Stimulating the Growth of Muscle Mass in People with Neuromuscular Diseases

Lindsey Lee Lair, Biohaven’s vice president of clinical development, discusses spinal muscular atrophy, the progress we’ve seen in treating the condition, and the company’s efforts to develop a therapy to stimulate the growth of muscle mass and strength in people with the disease.